Impact and Lived Experience of Parents of a Child With a Large or Giant Congenital Melanocytic Nevus
NCT ID: NCT06934759
Last Updated: 2025-12-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
30 participants
OBSERVATIONAL
2025-12-01
2026-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Children with congenital melanocytic nevus
No Intervention: Observational Cohort
There is no intervention
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
No Intervention: Observational Cohort
There is no intervention
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Willing to participate in a semi-structured interview
* Has received full information about the research and has not objected to participating or to the use of their data
* Able to understand and speak French
* Parent of a child under 18 years of age
Exclusion Criteria
* Not willing to participate
* Currently under legal protection (e.g., guardianship or curatorship)
* Cognitive and/or psychological impairments preventing participation in a semi-structured interview
* Poor understanding and/or expression of the French language
* Parent of a child over 18 years of age
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assistance Publique Hopitaux De Marseille
OTHER
Hôpital Necker-Enfants Malades
OTHER
Centre Hospitalier Universitaire de Nice
OTHER
University Hospital, Brest
OTHER
Annecy Hospital, France
UNKNOWN
Centre Hospitalier Universitaire Dijon
OTHER
Nantes University Hospital
OTHER
University Hospital, Grenoble
OTHER
Centre Hospitalier Universitaire de la Réunion
OTHER
Central Hospital, Nancy, France
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Anne Claire BURSZTEJN
Clinical Professor and Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre Hospitalier Régional Universitaire de Nancy
Nancy, France, France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2024PI238
Identifier Type: -
Identifier Source: org_study_id